Table of Contents
2019-2024 Global Fabry Disease Treatment Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Fabry Disease Treatment Market Size 2014-2024
2.1.2 Fabry Disease Treatment Market Size CAGR by Region
2.2 Fabry Disease Treatment Segment by Type
2.2.1 Enzyme Replacement Therapy (ERT)
2.2.2 Chaperone Treatment
2.2.3 Substrate Reduction Therapy (SRT)
2.2.4 Others
2.3 Fabry Disease Treatment Market Size by Type
2.3.1 Global Fabry Disease Treatment Market Size Market Share by Type (2014-2019)
2.3.2 Global Fabry Disease Treatment Market Size Growth Rate by Type (2014-2019)
2.4 Fabry Disease Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Fabry Disease Treatment Market Size by Application
2.5.1 Global Fabry Disease Treatment Market Size Market Share by Application (2014-2019)
2.5.2 Global Fabry Disease Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Fabry Disease Treatment by Players
3.1 Global Fabry Disease Treatment Market Size Market Share by Players
3.1.1 Global Fabry Disease Treatment Market Size by Players (2017-2019)
3.1.2 Global Fabry Disease Treatment Market Size Market Share by Players (2017-2019)
3.2 Global Fabry Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Fabry Disease Treatment by Regions
4.1 Fabry Disease Treatment Market Size by Regions
4.2 Americas Fabry Disease Treatment Market Size Growth
4.3 APAC Fabry Disease Treatment Market Size Growth
4.4 Europe Fabry Disease Treatment Market Size Growth
4.5 Middle East & Africa Fabry Disease Treatment Market Size Growth
5 Americas
5.1 Americas Fabry Disease Treatment Market Size by Countries
5.2 Americas Fabry Disease Treatment Market Size by Type
5.3 Americas Fabry Disease Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Fabry Disease Treatment Market Size by Countries
6.2 APAC Fabry Disease Treatment Market Size by Type
6.3 APAC Fabry Disease Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Fabry Disease Treatment by Countries
7.2 Europe Fabry Disease Treatment Market Size by Type
7.3 Europe Fabry Disease Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Fabry Disease Treatment by Countries
8.2 Middle East & Africa Fabry Disease Treatment Market Size by Type
8.3 Middle East & Africa Fabry Disease Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Fabry Disease Treatment Market Forecast
10.1 Global Fabry Disease Treatment Market Size Forecast (2019-2024)
10.2 Global Fabry Disease Treatment Forecast by Regions
10.2.1 Global Fabry Disease Treatment Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Fabry Disease Treatment Forecast by Type
10.8 Global Fabry Disease Treatment Forecast by Application
11 Key Players Analysis
11.1 Sanofi S.A.
11.1.1 Company Details
11.1.2 Fabry Disease Treatment Product Offered
11.1.3 Sanofi S.A. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Sanofi S.A. News
11.2 Shire Plc.
11.2.1 Company Details
11.2.2 Fabry Disease Treatment Product Offered
11.2.3 Shire Plc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Shire Plc. News
11.3 Amicus Therapeutics Inc.
11.3.1 Company Details
11.3.2 Fabry Disease Treatment Product Offered
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Amicus Therapeutics Inc. News
11.4 ISU Abxis Co Ltd.
11.4.1 Company Details
11.4.2 Fabry Disease Treatment Product Offered
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 ISU Abxis Co Ltd. News
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 Company Details
11.5.2 Fabry Disease Treatment Product Offered
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 JCR Pharmaceuticals Co Ltd. News
11.6 Protalix Biotherapeutics Inc.
11.6.1 Company Details
11.6.2 Fabry Disease Treatment Product Offered
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Protalix Biotherapeutics Inc. News
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Company Details
11.7.2 Fabry Disease Treatment Product Offered
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Idorsia Pharmaceuticals Ltd. News
11.8 Avrobio Inc.
11.8.1 Company Details
11.8.2 Fabry Disease Treatment Product Offered
11.8.3 Avrobio Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Avrobio Inc. News
11.9 Greenovation Biotech GmbH
11.9.1 Company Details
11.9.2 Fabry Disease Treatment Product Offered
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Greenovation Biotech GmbH News
11.10 Moderna Therapeutics Inc.
11.10.1 Company Details
11.10.2 Fabry Disease Treatment Product Offered
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Moderna Therapeutics Inc. News
11.11 Green Cross Pharma Pte Ltd.
12 Research Findings and Conclusion
